AI Summary
✦ ClarthaValuation Metrics
Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.
5Y Average
3.27
Current
2.26
Overvalued
3.76
Undervalued
2.78
5Y Average
2.49
Current
2.26
Overvalued
2.87
Undervalued
2.12
Peers & Comparison
Sector: Health Care · Theme: Pharmaceuticals
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
AKUMS DRUGS AND PHARMA L AKUMSPharmaceuticals | +9.6% | 5.9% | 44.4x Fair | +1% vs avg | +51.8% |
BLUE JET HEALTHCARE LTD BLUEJETPharmaceuticals | -17.4% | 26.5% | 43.8x Fair | -1% vs avg | -25.8% |
HIKAL LIMITED is compared against the Pharmaceuticals cohort. Peers include AKUMS DRUGS AND PHARMA L, BLUE JET HEALTHCARE LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹403 CrJun 2026Latest net profit
₹-7.50 CrJun 2026Latest EPS
₹-0.61Jun 2026Net margin
9.2%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 388.00 | 434.90 | 447.50 | 514.10 | 406.80 | 452.90 | 447.70 | 552.40 | 380.40 | 318.50 | 494.30 | 519.40 | 402.80 |
| Expenses + | 337.70 | 377.40 | 382.70 | 419.80 | 348.70 | 378.20 | 375.50 | 428.90 | 355.60 | 311.10 | 411.60 | 413.80 | 365.90 |
| Operating Profit | 50.30 | 57.50 | 64.80 | 94.30 | 58.10 | 74.70 | 72.20 | 123.50 | 24.80 | 7.40 | 82.70 | 105.60 | 36.90 |
| OPM % | 12.96% | 13.22% | 14.48% | 18.34% | 14.28% | 16.49% | 16.13% | 22.36% | 6.52% | 2.32% | 16.73% | 20.33% | 9.16% |
| Other Income + | 0.90 | 1.00 | 0.10 | 0.50 | 0.50 | 0.40 | 3.60 | 0.50 | 1.00 | 1.90 | -35.20 | -40.50 | 10.70 |
| Interest | 13.80 | 13.10 | 14.20 | 15.30 | 19.80 | 18.80 | 18.70 | 17.90 | 17.10 | 14.90 | 15.50 | 14.60 | 14.90 |
| Depreciation | 27.70 | 28.60 | 29.00 | 32.30 | 31.80 | 31.70 | 33.20 | 37.70 | 39.40 | 41.20 | 41.20 | 42.00 | 42.70 |
| Profit before tax | 9.70 | 16.80 | 21.70 | 47.20 | 7.00 | 24.60 | 23.90 | 68.40 | -30.70 | -46.80 | -9.20 | 8.50 | -10.00 |
| Tax % | 28.87% | 25.60% | 25.35% | 28.39% | 25.71% | 26.42% | 27.62% | 26.46% | -26.06% | -25.85% | -35.87% | -71.76% | -25.00% |
| Net Profit + | 6.90 | 12.50 | 16.20 | 33.80 | 5.20 | 18.10 | 17.30 | 50.30 | -22.70 | -34.70 | -5.90 | 14.60 | -7.50 |
| EPS in Rs | 0.56 | 1.01 | 1.31 | 2.74 | 0.42 | 1.47 | 1.40 | 4.08 | -1.84 | -2.81 | -0.48 | 1.18 | -0.61 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Announcement under Regulation 30 (LODR)-Press Release / Media Release